chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Upper-airway cough syndrome
Clinical narrative: postnasal drip; 2 ear aches; This spontaneous case was reported by a consumer and describes the occurrence of UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and EAR PAIN (2 ear aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and EAR PAIN (2 ear aches). The patient was treated with PREDNISOLONE at an unspecified dose and frequency. At the time of the report, UPPER-AIRWAY COUGH SYNDROME (postnasal drip) and EAR PAIN (2 ear aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by reporter.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site cellulitis
Clinical narrative: sore arm; injection site swelling, red about the size of a tennis ball- HCP dx cellulitis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) and VACCINATION SITE CELLULITIS (injection site swelling, red about the size of a tennis ball- HCP dx cellulitis) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cellulitis (the patient had symptoms like cellulitis.) on 17-Jan-2021. Concomitant products included ROSUVASTATIN, METOPROLOL and LEVOTHYROXINE for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE CELLULITIS (injection site swelling, red about the size of a tennis ball- HCP dx cellulitis). The patient was treated with NEOMYCIN SULFATE, POLYMYXIN B SULFATE (ANTIBIOTIC [NEOMYCIN SULFATE;POLYMYXIN B SULFATE]) (oral) on 17-Jan-2021 for Cellulitis, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and VACCINATION SITE CELLULITIS (injection site swelling, red about the size of a tennis ball- HCP dx cellulitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Joint injury
Clinical narrative: slipped and broke her ankle; This spontaneous case was reported by a consumer and describes the occurrence of JOINT INJURY (slipped and broke her ankle) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced JOINT INJURY (slipped and broke her ankle). At the time of the report, JOINT INJURY (slipped and broke her ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25-May-202 contains no significant information.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Injection site is red; injection site itching; Headache; sore left arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (sore left arm), VACCINATION SITE PRURITUS (injection site itching), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (Injection site is red) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore left arm) and HEADACHE (Headache). On 26-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itching). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is red). On 19-Jan-2021, HEADACHE (Headache) had resolved. On 20-Jan-2021, PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   .
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Neck pain, Pruritus, Rash, Vaccination site pain
Clinical narrative: Minor itchiness by the upper body; Pain going down from the side on my neck; Warm by the rash; Rash on the chest; Soreness at injection; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Minor itchiness by the upper body), NECK PAIN (Pain going down from the side on my neck), FEELING HOT (Warm by the rash), RASH (Rash on the chest) and VACCINATION SITE PAIN (Soreness at injection) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     no specified medical history was reported.  Concomitant products included LISINOPRIL and VITAMINS NOS for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PRURITUS (Minor itchiness by the upper body), NECK PAIN (Pain going down from the side on my neck), FEELING HOT (Warm by the rash), RASH (Rash on the chest) and VACCINATION SITE PAIN (Soreness at injection). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (Minor itchiness by the upper body), NECK PAIN (Pain going down from the side on my neck), FEELING HOT (Warm by the rash), RASH (Rash on the chest) and VACCINATION SITE PAIN (Soreness at injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Irritability, Myalgia
Clinical narrative: Irritable; Severe Headache; Extreme Fatigue; Muscle Aches; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABILITY (Irritable), HEADACHE (Severe Headache), FATIGUE (Extreme Fatigue) and MYALGIA (Muscle Aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included DOXYCYCLINE for Skin damage.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced IRRITABILITY (Irritable), HEADACHE (Severe Headache), FATIGUE (Extreme Fatigue) and MYALGIA (Muscle Aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, IRRITABILITY (Irritable), HEADACHE (Severe Headache), FATIGUE (Extreme Fatigue) and MYALGIA (Muscle Aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, SARS-CoV-2 test, Vertigo
Clinical narrative: Vertigo; Itchiness on arm; Rash from elbow the elbow to the shoulder (injection arm); This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), PRURITUS (Itchiness on arm) and RASH (Rash from elbow the elbow to the shoulder (injection arm)) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from November 2020 to December 2020. Concomitant products included ROSUVASTATIN for Cholesterol, CLOPIDOGREL, METOPROLOL SUCCINATE (METOPROLOL [METOPROLOL SUCCINATE]), LISINOPRIL, ALLOPURINOL, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and COPD Inhaler for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PRURITUS (Itchiness on arm) and RASH (Rash from elbow the elbow to the shoulder (injection arm)). On 21-Feb-2021, the patient experienced VERTIGO (Vertigo). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and HYDROCORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo), PRURITUS (Itchiness on arm) and RASH (Rash from elbow the elbow to the shoulder (injection arm)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling
Clinical narrative: Knot in cubital fossa; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Knot in cubital fossa) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced JOINT SWELLING (Knot in cubital fossa). At the time of the report, JOINT SWELLING (Knot in cubital fossa) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was received by the patient.  No concomitant medication was received by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up was received on 06-JUL-2021: contains non significant information.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia, Pruritus, Rash
Clinical narrative: Red, itchy,slightly tinted rash on his collar bone and the top of his sternum; Tingling sensation; Red, itchy,slightly tinted rash on his collar bone and the top of his sternum; Slightly tinted rash on his collar bone and the top of his sternum; The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso). The patient was treated with HYDROCORTISONE ongoing since an unknown date for Rash, at an unspecified dose and frequency and LORATADINE (CLARITIN [LORATADINE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PRURITUS (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), PARAESTHESIA (Tingling sensation), ERYTHEMA (Red, itchy,slightly tinted rash on his collar bone and the top of his sternum), RASH (Slightly tinted rash on his collar bone and the top of his sternum) and RASH (The rash increasingly spread to his stomach with a lighter rash in places around his under arm but not in his arm pit, down his arm, and down the side of his torso) outcome was unknown.            The concomitant medications were not provided.  Treatment medication also included antifungal cream.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash, Vaccination site swelling
Clinical narrative: arm swelled, big patch; broke out with all body rash; a lot of swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled, big patch), RASH (broke out with all body rash) and VACCINATION SITE SWELLING (a lot of swelling at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelled, big patch), RASH (broke out with all body rash) and VACCINATION SITE SWELLING (a lot of swelling at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm swelled, big patch), RASH (broke out with all body rash) and VACCINATION SITE SWELLING (a lot of swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Lip dry, Pruritus
Clinical narrative: Itching from head to toe; Tongue was very dry; A spontaneous report was received from a consumer concerning a 73-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itching from head to toe, tongue was very dry.  The patient's medical history was not provided. Concomitant medications reported were Blood pressure meds, Vitamin d 3, Baby aspirin, Calcium for drug use for unknown indication.  On 29 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012k20a) intramuscularly for prophylaxis of COVID-19 infection.  On 29 Jan 2021, the patient experienced the event(s) itching from head to toe, tongue was very dry.  Treatment details included Zyrtec.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), itching from head to toe, tongue was very dry was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: body aches; chills; light headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), CHILLS (chills) and HEADACHE (light headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches), CHILLS (chills) and HEADACHE (light headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, MYALGIA (body aches), CHILLS (chills) and HEADACHE (light headache) outcome was unknown.            Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Red welt at injection site; Pain at injection site/Tenderness at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Red welt at injection site), VACCINATION SITE PAIN (Pain at injection site/Tenderness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     no specified medical history was reported.  Concomitant products included LISINOPRIL and PRAVASTATIN for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Red welt at injection site), VACCINATION SITE PAIN (Pain at injection site/Tenderness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (Red welt at injection site), VACCINATION SITE PAIN (Pain at injection site/Tenderness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Feeling abnormal, Limb discomfort, Paraesthesia
Clinical narrative: Tingling on left side of the face; Weird thinking; Weird dreams; Heavy foot feeling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking), ABNORMAL DREAMS (Weird dreams) and LIMB DISCOMFORT (Heavy foot feeling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, LEVOTHYROXINE SODIUM (SYNTHROID), VENLAFAXINE HYDROCHLORIDE (EFFEXOR), AMLODIPINE BESILATE (NORVASC), LOSARTAN and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking), ABNORMAL DREAMS (Weird dreams) and LIMB DISCOMFORT (Heavy foot feeling). The patient was treated with PARACETAMOL (TYLENOL) for product used for unkown indication, at an unspecified dose and frequency. On 25-Jan-2021, PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking) and ABNORMAL DREAMS (Weird dreams) had resolved. At the time of the report, LIMB DISCOMFORT (Heavy foot feeling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-021655 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site paraesthesia
Clinical narrative: tingling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PARAESTHESIA (tingling at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PARAESTHESIA (tingling at injection site). At the time of the report, VACCINATION SITE PARAESTHESIA (tingling at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Follow-up received on 16-Apr-2021 included no new information.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: swelling in the right arm; rash in the right arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (swelling in the right arm) and VACCINATION SITE RASH (rash in the right arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013l20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling in the right arm) and VACCINATION SITE RASH (rash in the right arm). At the time of the report, VACCINATION SITE SWELLING (swelling in the right arm) and VACCINATION SITE RASH (rash in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment: The patient was given antihistamine and cream as treatment.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Covid19; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Covid19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Dec-2020, the patient experienced COVID-19 (Covid19). On 14-Jan-2021, COVID-19 (Covid19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Mobility decreased, Pain in extremity
Clinical narrative: Concomitant products included PARACETAMOL (TYLENOL), TRAMADOL, ACETYLSALICYLIC ACID (BABY ASPIRIN), MULTIVITAMIN & MINERAL, ATORVASTATIN and METOPROLOL for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in my left arm). On an unknown date, the patient experienced MOBILITY DECREASED (trouble lifting my left arm/still have some limited use of my arm/still having complications with my arm.) and DISCOMFORT (No longer tolerate the pain and discomfort). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) for Pain, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in my left arm) had not resolved and MOBILITY DECREASED (trouble lifting my left arm/still have some limited use of my arm/still having complications with my arm.) and DISCOMFORT (No longer tolerate the pain and discomfort) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No medical history provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Event outcome updated.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure systolic increased
Clinical narrative: blood pressure was 180/73; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE SYSTOLIC INCREASED (blood pressure was 180/73) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included ANASTROZOLE and HYDRALAZINE for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE SYSTOLIC INCREASED (blood pressure was 180/73). At the time of the report, BLOOD PRESSURE SYSTOLIC INCREASED (blood pressure was 180/73) had resolved.            The patient reported that the reason her blood pressure had raised so high was a medication that she was recently put on around the time of the vaccination series, Anastrozole 1MG. Her physician prescribed her Hydralazine 50MG and her blood pressure was back to normal range.    NO treatment medication information provided.   This case was linked to MOD-2021-021868, MOD-2021-021868 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Concomitant medication added in the products tab. Event outcome updated.
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: pain from elbow to wrist; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain from elbow to wrist) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (pain from elbow to wrist). At the time of the report, PAIN (pain from elbow to wrist) outcome was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Dry skin, Erythema, Lymphadenopathy, Pain
Clinical narrative: extremely dry on areas of body,scaly on areas of body; Skin feels sore; swollen lymph node in left armpit like a shelled pecan which hurts; itching all over body; blisters (sores) on top of hands/Skin feels sore; redness around nose,red on areas of body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching all over body), BLISTER (blisters (sores) on top of hands/Skin feels sore), ERYTHEMA (redness around nose,red on areas of body), DRY SKIN (extremely dry on areas of body,scaly on areas of body) and PAIN (Skin feels sore) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included GLIMEPIRIDE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), AMLODIPINE BESILATE (NORVASC), APIXABAN (ELIQUIS), FUROSEMIDE (LASIX [FUROSEMIDE]), POTASSIUM, RANOLAZINE (RANEXA), ATORVASTATIN, CLONAZEPAM (CLONOPIN), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), LISINOPRIL, MAGNESIUM CARBONATE (MAGENSIUM VITAFIT), DULOXETINE HYDROCHLORIDE (CYMBALTA), TIZANIDINE, CICLOSPORIN (RESTASIS) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PRURITUS (itching all over body), BLISTER (blisters (sores) on top of hands/Skin feels sore), ERYTHEMA (redness around nose,red on areas of body) and LYMPHADENOPATHY (swollen lymph node in left armpit like a shelled pecan which hurts). On an unknown date, the patient experienced DRY SKIN (extremely dry on areas of body,scaly on areas of body) and PAIN (Skin feels sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching all over body), BLISTER (blisters (sores) on top of hands/Skin feels sore), ERYTHEMA (redness around nose,red on areas of body), DRY SKIN (extremely dry on areas of body,scaly on areas of body), PAIN (Skin feels sore) and LYMPHADENOPATHY (swollen lymph node in left armpit like a shelled pecan which hurts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: extremely dry on areas of body,scaly on areas of body; Skin feels sore; swollen lymph node in left armpit like a shelled pecan which hurts; itching all over body; blisters (sores) on top of hands/Skin feels sore; redness around nose,red on areas of body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching all over body), BLISTER (blisters (sores) on top of hands/Skin feels sore), ERYTHEMA (redness around nose,red on areas of body), DRY SKIN (extremely dry on areas of body,scaly on areas of body) and PAIN (Skin feels sore) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included GLIMEPIRIDE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), AMLODIPINE BESILATE (NORVASC), APIXABAN (ELIQUIS), FUROSEMIDE (LASIX [FUROSEMIDE]), POTASSIUM, RANOLAZINE (RANEXA), ATORVASTATIN, CLONAZEPAM (CLONOPIN), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF), LISINOPRIL, MAGNESIUM CARBONATE (MAGENSIUM VITAFIT), DULOXETINE HYDROCHLORIDE (CYMBALTA), TIZANIDINE, CICLOSPORIN (RESTASIS) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PRURITUS (itching all over body), BLISTER (blisters (sores) on top of hands/Skin feels sore), ERYTHEMA (redness around nose,red on areas of body) and LYMPHADENOPATHY (swollen lymph node in left armpit like a shelled pecan which hurts). On an unknown date, the patient experienced DRY SKIN (extremely dry on areas of body,scaly on areas of body) and PAIN (Skin feels sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PRURITUS (itching all over body), BLISTER (blisters (sores) on top of hands/Skin feels sore), ERYTHEMA (redness around nose,red on areas of body), DRY SKIN (extremely dry on areas of body,scaly on areas of body), PAIN (Skin feels sore) and LYMPHADENOPATHY (swollen lymph node in left armpit like a shelled pecan which hurts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Heart rate irregular, Myalgia, Pain in extremity
Clinical narrative: Irregular heart beat; Short of breath; Sore arm; Low grade fever; Chills; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE IRREGULAR (Irregular heart beat), DYSPNOEA (Short of breath), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Open heart surgery.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DYSPNOEA (Short of breath), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low grade fever), CHILLS (Chills) and MYALGIA (Muscle ache). On 27-Jan-2021, the patient experienced HEART RATE IRREGULAR (Irregular heart beat). At the time of the report, HEART RATE IRREGULAR (Irregular heart beat), DYSPNOEA (Short of breath), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low grade fever), CHILLS (Chills) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Irregular heart beat; Short of breath; Sore arm; Low grade fever; Chills; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE IRREGULAR (Irregular heart beat), DYSPNOEA (Short of breath), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low grade fever) and CHILLS (Chills) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Open heart surgery.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DYSPNOEA (Short of breath), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low grade fever), CHILLS (Chills) and MYALGIA (Muscle ache). On 27-Jan-2021, the patient experienced HEART RATE IRREGULAR (Irregular heart beat). At the time of the report, HEART RATE IRREGULAR (Irregular heart beat), DYSPNOEA (Short of breath), PAIN IN EXTREMITY (Sore arm), PYREXIA (Low grade fever), CHILLS (Chills) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Vaccination site rash; Vaccination site pruritus; Vaccination site rash; Vaccination site pruritus; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of VACCINATION SITE RASH (Vaccination site rash), the second episode of VACCINATION SITE RASH (Vaccination site rash), the first episode of VACCINATION SITE PRURITUS (Vaccination site pruritus) and the second episode of VACCINATION SITE PRURITUS (Vaccination site pruritus) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 044A21A) for COVID-19 vaccination.     no specified medical history was reported.  The patient's past medical history included Hives. Concurrent medical conditions included Chronic pain (back and leg pain) since 1989, Drug allergy (Augmentin), Drug allergy (Biaxin), Drug allergy (some anesthetics used for surgery), Drug allergy (Naperson), Dug allergy (Ibuprofen), Drug allergy (Indocin), Drug allergy (Feldene,), Hypersensitivity, Asthma and Hay fever. Concomitant products included OXYCODONE HYDROCHLORIDE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]), GABAPENTIN, CETIRIZINE HYDROCHLORIDE (ZYRTEC R), ESTRADIOL (ESTROGEL), HCTZ, VITAMIN E NOS, FISH OIL, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN, MAGNESIUM, BIOTIN and SALBUTAMOL (PROVENTIL [SALBUTAMOL]) for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021 at 11:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 13-Feb-2021, the patient experienced the first episode of VACCINATION SITE RASH (Vaccination site rash) and the first episode of VACCINATION SITE PRURITUS (Vaccination site pruritus). On 15-Feb-2021, the patient experienced the second episode of VACCINATION SITE PRURITUS (Vaccination site pruritus). On 19-Feb-2021, the patient experienced the second episode of VACCINATION SITE RASH (Vaccination site rash). On 15-Feb-2021, last episode of VACCINATION SITE PRURITUS (Vaccination site pruritus) had resolved. At the time of the report, last episode of VACCINATION SITE RASH (Vaccination site rash) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also uses unspecified fiber pill  as a  concomitant medication.  No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up received on 21-JUN-2021. Patient history added, concomitant medication information added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Skin irritation
Clinical narrative: Scalp started itching Scalp started itching and felt like wanting to pull the head off; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (Scalp started itchingScalp started itching and felt like wanting to pull the head off) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced SKIN IRRITATION (Scalp started itchingScalp started itching and felt like wanting to pull the head off). On 21-Feb-2021, SKIN IRRITATION (Scalp started itchingScalp started itching and felt like wanting to pull the head off) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Neuralgia, Pain, Peripheral swelling
Clinical narrative: Lump Opposite Arm; Large raised lump in legs; Orthopedic nerve pain; Burning pain in all over of body; This spontaneous case was reported by a consumer and describes the occurrence of MASS (Lump Opposite Arm), PERIPHERAL SWELLING (Large raised lump in legs), NEURALGIA (Orthopedic nerve pain) and PAIN (Burning pain in all over of body) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in August 2020.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced MASS (Lump Opposite Arm), PERIPHERAL SWELLING (Large raised lump in legs), NEURALGIA (Orthopedic nerve pain) and PAIN (Burning pain in all over of body). At the time of the report, MASS (Lump Opposite Arm), PERIPHERAL SWELLING (Large raised lump in legs), NEURALGIA (Orthopedic nerve pain) and PAIN (Burning pain in all over of body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Injection site pain, Underdose
Clinical narrative: Some of the vaccine spilled out and not all of it went into arm; Some of the vaccine spilled out and not all of it went into arm; Arm hurts big time, sore; A spontaneous report was received from a consumer concerning a 72-year-old, male patient who experienced some of the vaccine spilled out and not all of it went into arm/underdose, device connection issue and arm hurts big time and is sore/injection site pain.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 20 Feb 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (lot number 043L20A) intramuscularly in the right upper arm for prophylaxis of COVID-19 infection.   On 20FEB2021, the patient reported that he did not receive the full dose of the vaccine. He saw that the person dispensing it withdrew the needle with product still inside, which spilled out upon withdrawal. He also reported that his arm hurt big time and felt sore.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, underdose and device connection issue were recovered/resolved.  The outcome of the event, injection site pain was unknown.; Reporter's Comments: This report refers to a case of underdose and device connection issue for mRNA-1273 (lot # 043L20A) with associated AE reported as injection site pain.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: Hernia, Injection site pain
Clinical narrative: emergency hernia surgery; arm pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (arm pain at injection site) and HERNIA (emergency hernia surgery) in a 49-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN and AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced INJECTION SITE PAIN (arm pain at injection site). On 02-Feb-2021, the patient experienced HERNIA (emergency hernia surgery). At the time of the report, INJECTION SITE PAIN (arm pain at injection site) and HERNIA (emergency hernia surgery) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: arm was "killing her"; sore arm injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm injection site) and PAIN IN EXTREMITY (arm was "killing her") in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore arm injection site). On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was "killing her"). At the time of the report, VACCINATION SITE PAIN (sore arm injection site) and PAIN IN EXTREMITY (arm was "killing her") was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included Asthma (she used an albuterol inhaler as needed two years ago).    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with PREDNISONE at an unspecified dose and frequency and ACICLOVIR SODIUM (ACYCLOVIR ABBOTT VIAL) at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 04-Jan-2021, the patient reported red bumps on her back. She went to a health care provider who purportedly misdiagnosed the area as poison oak/ivy and she was prescribed prednisone. She sought a second opinion and was diagnosed with Shingles by another health care provider who prescribed Acyclovir (three times a day), which she was still taking at the time of the report. At the time of the report (27-Jan-2021) she described the area as now being dried up, scabbed up and red.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Initial additional information.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: shingle like hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (shingle like hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (shingle like hives). At the time of the report, URTICARIA (shingle like hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and CHILLS (Chills) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced CHILLS (Chills). On 21-Feb-2021, the patient experienced PYREXIA (Fever). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.